O IMPACTO DO USO DE HIPOGLICEMIANTES NO TRATAMENTO DA OBESIDADE: UMA REVISÃO INTEGRATIVA
DOI:
https://doi.org/10.36557/2674-8169.2024v6n11p1839-1851Keywords:
Hipoglicemiantes, Obesidade, Emagrecimento, Diabetes, SemaglutidaAbstract
Obesity can be explained, in a simple way, as a deposit of body fat that is related to health risks, as it is related to many metabolic complications. General Objective: to describe the impact of hypoglycemic agents in the treatment of obesity. Methodology: The collection of information for the bibliographic research occurred through the exploration of the databases of the Virtual Health Library (BVS), Virtual Electronic Scientific Library (SCIELO) and Latin American and Caribbean Literature in Health Sciences (LILACS). Results and Discussion: The main hypoglycemic agents used in the treatment of diabetes and consequently influential in weight loss are Sulfonylureas, Biguanides Meglitinides, Thiazolidinediones, dipeptidyl peptidase IV inhibitors, and alpha glucosidase inhibitors. Final Considerations: Through the development of this study, it was possible to understand the mechanism of action of hypoglycemic agents used in weight loss, considering that this is an adverse reaction of drug treatment for diabetes. It is worth noting that the benefits of hypoglycemic agents are linked not only to weight loss, but also to the control of the underlying disease, glycemic control, better quality of life, better disposition, among others. They do not exempt risks, such as those associated with glycemic dysregulation, the development of diabetic ketoacidosis and coma related to a sudden drop in blood glucose.
Downloads
References
ASSOCIAÇÃO BRASILEIRA DE NORMAS TÉCNICAS. NBR 15287: informação e documentação – Projeto de Pesquisa – Apresentação. Rio de Janeiro, 2011.
BADANAI, N.L.; et al. Association of dietary patterns and degree of food processing with feelings of depression in pregnancy. Rev Bras Saude Mater Infant. 2019 Jul/Set; 19 (3): 591-600.
BROWN, J. et al. Insulin for the treatment of women with gestational diabetes, Cochrane Database of Systematic Reviews, n. 11, 2017.
CABRAL, I. E. G. et al. Impacto saúde doença no controle de peso com uso de hipoglicemiantes da classe análogos do glp-1. Revista Multidisciplinar em Saúde, v. 4, n. 1, 2023.
COSTA, A.F. et al. Carga do diabetes mellitus tipo 2 no Brasil. Cadernos de saúde pública, Rio de Janeiro, v. 33, n. 2, p.1-14, 2018.
DOMINGOS, G.F.; et al. Hipoglicemiantes orais: uma análise de seus efeitos, indicações e contraindicações. Revista Foco. Curitiba (PR). v.17.n.4, e4833, p.01-15, 2024.
DUNCAN, B.B.; et al. The burden of diabetes and hyperglycemia in Brazil and its states: findings from the Global Burden of Disease Study 2015. Revista Brasileira de Epidemiologia, v. 20, p. 90-101, 2018.
FARRAR, D.; et al. Treatments for gestational diabetes: a systematic review and meta-analysis, BMJ Open, v. 7, n. 6, p. e015557, 2017.
GHOMIAN, N.; et al. The efficacy of metformin compared with insulin. In: GHOMIAN et al. Regulating blood glucose levels during gestational diabetes mellitus: a randomized clinical trial. Journal of Cellular Physiology, v. 234, n. 4, p. 4695-4701, 2019.
GRAY, S.G.; et al. The emerging role of metformin in gestational diabetes mellitus. Diabetes, Obesity And Metabolism, v. 19, n. 6, p. 765-772, 24 mar. 2018.
IBGE. Instituto Brasileiro de Geografia e Estatística. Obesidade no Brasil. 2024.
JERÔNIMO, P.S.; et al. Terapia nutricional e diabetes mellitus gestacional: uma revisão bibliográfica. 2018. Monografia [Trabalho de conclusão do curso de nutrição]. Universidade Federal de Campina Grande, 2018.
KINTIRAKI, E.; et al. Gestational diabetes mellitus: multi-disciplinary treatment approaches. Metabolism, [S.L.], v. 86, p. 91-101, set. 2018.
LEITE, S.S.; et al. Construction and validation of na educational content validation instrument in health. Rev Bras Enferm. 2018; 71 (Supl 4): S1635-S41
MARQUES, I.C. Diabetes mellitus: principais aspectos e diagnóstico através da dosagem de hemoglobina glicada. 2018. Monografia [Trabalho de concluão do curso de Farmácia]. Universidade Federal de Ouro Preto, 2018.
NUNES, R.D; et al. Two criteria of oral glucose tolerance test to diagnose gestational diabetes mellitus. Revista da Associação Médica Brasileira, [S.L.], v. 66, n. 2, p. 139-145, fev. 2020.
OLIVEIRA, S.C.; et al. Efeito de uma intervenção educativa na gravidez: ensaio clínico randomizado em cluster. Acta Paul Enferm. 2018 Jun; 31 (3): 291-8.
SALES, W. B.; et al. Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women, Revista Brasileira de Ginecologia e Obstetrícia, v. 40, n. 4, p. 180-187, 2018.
SILVA, N.V.S.R.; et al. Atenção farmacêutica ao uso de hipoglicemiantes no processo de emagrecimento. Revista Ibero- Americana de Humanidades, Ciências e Educação- REASE. São Paulo, v.9.n.09. set. 2023.
TARRY-ADKINS, J.L.; et al. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLOS Medicine, v. 16, n. 8, p. e1002848, 2019.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Adalúcia Grangeiro da Rocha, Gilmara Moreira da Silva, Luciane Marinho Avinte , Larissa Aguiar de Mendonça
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.
